Palladino MJ: Difference between revisions
From Bioblast
Purtschera (talk | contribs) No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Person | {{Person | ||
|lastname=Palladino | |||
|firstname=Michael John | |firstname=Michael John | ||
| | |title=Associate Professor, PhD | ||
|address= | |address=Department Med-Pharmacology and Chem Bio | ||
Department Med-Pharmacology and Chem Bio | |||
Pittsburgh Institute for Neurodegenerative Diseases (PIND) | Pittsburgh Institute for Neurodegenerative Diseases (PIND) | ||
| Line 13: | Line 12: | ||
Pittsburgh, PA 15260, USA | Pittsburgh, PA 15260, USA | ||
}} | }} | ||
Mitochondrial disease | Mitochondrial disease modules. | ||
Revision as of 12:04, 15 April 2012
| Name | Palladino Michael John, Associate Professor, PhD |
|---|---|
| Institution | |
| Address | Department Med-Pharmacology and Chem Bio
Pittsburgh Institute for Neurodegenerative Diseases (PIND) University of Pittsburgh SOM Pittsburgh, PA 15260, USA, |
| City | |
| State/Province | |
| Country | |
| [email protected] | |
| Weblink | |
| O2k-Network Lab | US PA Pittsburgh Palladino MJ |
Mitochondrial disease modules.
